Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies-Reference-Cited by-同舟云学术

Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies

Published:2021-01 Issue:1 Volume:110 Page:422-431
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Kanebratt Kajsa P.,Janefeldt Annika,Vilén Liisa,Vildhede Anna,Samuelsson Kristin,Milton Lucas,Björkbom Anders,Persson Marie,Leandersson Carina,Andersson Tommy B.,Hilgendorf Constanze

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference58 articles.

1. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds;Sohlenius-Sternbeck;Xenobiotica,2010

2. Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes;Sohlenius-Sternbeck;Xenobiotica,2012

3. Importance of the unstirred water layer and hepatocyte membrane integrity in vitro for quantification of intrinsic metabolic clearance;Wood;Drug Metab Dispos,2018

4. Addressing the challenges of low clearance in drug research;Di;AAPS J,2015

5. Low-turnover drug molecules: a current challenge for drug metabolism scientists;Hutzler;Drug Metab Dispos,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogenic Responsiveness of Brown Trout Primary Hepatocyte Spheroids to Environmental Levels of 17α-Ethinylestradiol;Journal of Xenobiotics;2024-08-06

2. OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids;Scientific Reports;2024-07-27

3. 3D culture models to study pathophysiology of steatotic liver disease;Atherosclerosis;2024-06

4. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction;Toxicology;2024-06

5. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds;DRUG METAB DISPOS;2024